CTT Pharmaceutical Holdings IncOTC Pink - Current Information:CTTH
- LAST PRICE0.0679
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0510/ 100
- Ask / Lots0.0679/ 292
- Open / Previous Close--- / 0.0679
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Oct 29, 2024
CTT Pharma's CEO Speaks at FDA and NIH Meeting for Advancing Smoking Cessation, from 7:01AM ET on Tuesday Oct 29, 2024 by Dow Jones
7:01AM ET on Tuesday Oct 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CTT Pharmaceutical Holdings Inc | 3.6M | -0.8x | --- |
Channel Therapeutics Corp | 3.6M | -0.4x | --- |
NuCana PLC | 2.9M | 0.0x | --- |
Artelo Biosciences Inc | 3.6M | -0.4x | --- |
Dogwood Therapeutics Inc | 3.6M | -0.5x | --- |
Enzolytics Inc | 3.5M | 0.0x | --- |
Company Information
CTT Pharmaceutical Holdings, Inc. is a development stage company. The Company is specialized in drug delivery systems technology within the pharmaceutical industry. The Company is focused is on fast dissolving drug delivery systems through the development of advanced oral delivery thin wafers. The Company plans to specialize in the development of oral drug delivery systems for pain management and treatment. Film strip encapsulated with the actives to help in pain reduction can include many combinations to help reduce pain and addiction and help patient safely. Oral Thin strips helps in pain management and inflammation indications, such as Arthritis. The Company has invented an ideal intra oral, fast-dissolving drug delivery system. This novel intraoral drug delivery system is its proprietary patented technology and is a thin, flexible and quick-dissolving film.
Contact Information
- Headquarters
- 3853 Northdale Blvd #268TAMPA, FL, United States 33624
- Phone
- 813-606-0060
- Fax
- 302-636-5454
Executives
- President, Director
- William Birge
- Chief Executive Officer and Chief Science Officer, Director
- Pankaj Modi
- Chief Financial Officer
- Robert Allen
- Treasurer, Secretary, Director
- Dean Hanisch
- Director
- Allen Greenspoon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 53.6M |
CTT Pharmaceutical Holdings Inc does not pay a dividend. | |
Beta | 0.64 |
EPS | $-0.08 |
Book Value | $0.08 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
